Gain Therapeutics, Inc. (GANX)
1.26
-0.03
(-2.33%)
USD |
NASDAQ |
Oct 23, 16:00
1.33
+0.07
(+5.56%)
After-Hours: 20:00
Gain Therapeutics Price to Book Value : 4.836 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 4.836 |
| October 22, 2026 | 4.951 |
| October 21, 2026 | 4.568 |
| October 20, 2026 | 4.568 |
| October 19, 2026 | 4.798 |
| October 16, 2026 | 4.836 |
| October 15, 2026 | 5.105 |
| October 14, 2026 | 5.066 |
| October 13, 2026 | 5.412 |
| October 12, 2026 | 6.026 |
| October 09, 2026 | 6.295 |
| October 08, 2026 | 6.199 |
| October 07, 2026 | 6.410 |
| October 06, 2026 | 6.410 |
| October 05, 2026 | 6.486 |
| October 02, 2026 | 6.563 |
| October 01, 2026 | 6.602 |
| September 30, 2026 | 6.640 |
| September 29, 2026 | 6.448 |
| September 28, 2026 | 6.794 |
| September 25, 2026 | 6.832 |
| September 24, 2026 | 7.062 |
| September 23, 2026 | 7.062 |
| September 22, 2026 | 7.484 |
| September 21, 2026 | 7.062 |
| Date | Value |
|---|---|
| September 18, 2026 | 6.755 |
| September 17, 2026 | 6.832 |
| September 16, 2026 | 6.602 |
| September 15, 2026 | 6.563 |
| September 14, 2026 | 6.678 |
| September 11, 2026 | 6.717 |
| September 10, 2026 | 6.563 |
| September 09, 2026 | 6.602 |
| September 08, 2026 | 7.024 |
| September 04, 2026 | 6.909 |
| September 03, 2026 | 6.986 |
| September 02, 2026 | 6.870 |
| September 01, 2026 | 6.794 |
| August 31, 2026 | 6.909 |
| August 28, 2026 | 6.794 |
| August 27, 2026 | 7.101 |
| August 26, 2026 | 6.947 |
| August 25, 2026 | 7.312 |
| August 24, 2026 | 7.676 |
| August 21, 2026 | 7.696 |
| August 20, 2026 | 7.600 |
| August 19, 2026 | 7.945 |
| August 18, 2026 | 7.792 |
| August 17, 2026 | 7.830 |
| August 14, 2026 | 8.137 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.599 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
| Anika Therapeutics, Inc. | 2.088 |
| Savara, Inc. | 6.034 |
| Vericel Corp. | 5.881 |
Price to Book Value Related Metrics
| Price | 1.26 |
| Earnings Yield | -40.16% |
| Market Cap | 54.61M |